Literature DB >> 20484984

PINK1 points Parkin to mitochondria.

Cristofol Vives-Bauza1, Serge Przedborski.   

Abstract

For decades, it has been presumed that mitochondrial dysfunction, in the form of impaired complex I activity, may contribute to the cause of Parkinson disease (PD). ( 1) The discovery that several gene mutations cause familial forms of PD ( 1) has led to a renewed enthusiasm for the mitochondrial hypothesis of PD, but this time from a quite distinct and, perhaps, more realistic angle. Among these genes, those that code for PTEN-induced kinase-1 (PINK1) ( 2) and for the E3-ubiquitin ligase Parkin ( 3) did attract major interest from mitochondriologists, in part, because both proteins interact with each other and apparently function, genetically, within the same molecular pathway to modulate mitochondrial dynamics in Drosophila. ( 4-6).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20484984     DOI: 10.4161/auto.6.5.12068

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  12 in total

Review 1.  Recent advances in the genetics of Parkinson's disease.

Authors:  Ian Martin; Valina L Dawson; Ted M Dawson
Journal:  Annu Rev Genomics Hum Genet       Date:  2011       Impact factor: 8.929

Review 2.  Mitochondrial dynamics: the intersection of form and function.

Authors:  Andrew Ferree; Orian Shirihai
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

3.  PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease.

Authors:  Joo-Ho Shin; Han Seok Ko; Hochul Kang; Yunjong Lee; Yun-Il Lee; Olga Pletinkova; Juan C Troconso; Valina L Dawson; Ted M Dawson
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

4.  Chronic treatment with the complex I inhibitor MPP+ depletes endogenous PTEN-induced kinase 1 (PINK1) via up-regulation of Bcl-2-associated athanogene 6 (BAG6).

Authors:  Manish Verma; Jianhui Zhu; Kent Z Q Wang; Charleen T Chu
Journal:  J Biol Chem       Date:  2020-04-24       Impact factor: 5.157

5.  The emerging role of proteolysis in mitochondrial quality control and the etiology of Parkinson's disease.

Authors:  Riya Shanbhag; Guang Shi; Jarungjit Rujiviphat; G Angus McQuibban
Journal:  Parkinsons Dis       Date:  2012-05-13

6.  Brain region specific mitophagy capacity could contribute to selective neuronal vulnerability in Parkinson's disease.

Authors:  Joachim Klose; Lei Mao; Madeleine Diedrich; Tohru Kitada; Grit Nebrich; Andrea Koppelstaetter; Jie Shen; Claus Zabel
Journal:  Proteome Sci       Date:  2011-09-23       Impact factor: 2.480

Review 7.  New therapeutics to modulate mitochondrial dynamics and mitophagy in cardiac diseases.

Authors:  Marie-Hélène Disatnik; Sunhee Hwang; Julio C B Ferreira; Daria Mochly-Rosen
Journal:  J Mol Med (Berl)       Date:  2015-02-05       Impact factor: 4.599

8.  Microglial AGE-albumin is critical for neuronal death in Parkinson's disease: a possible implication for theranostics.

Authors:  Enkhjargal Bayarsaikhan; Delger Bayarsaikhan; Jaesuk Lee; Myeongjoo Son; Seyeon Oh; Jeongsik Moon; Hye-Jeong Park; Arivazhagan Roshini; Seung U Kim; Byoung-Joon Song; Seung-Mook Jo; Kyunghee Byun; Bonghee Lee
Journal:  Int J Nanomedicine       Date:  2016-08-23

Review 9.  The pallidopyramidal syndromes: nosology, aetiology and pathogenesis.

Authors:  Eleanna Kara; John Hardy; Henry Houlden
Journal:  Curr Opin Neurol       Date:  2013-08       Impact factor: 5.710

10.  SESN2 facilitates mitophagy by helping Parkin translocation through ULK1 mediated Beclin1 phosphorylation.

Authors:  Ashish Kumar; Chandrima Shaha
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.